Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Synthetic cannabinoid molecule created for osteoarthritis

Synthetic cannabinoid molecule created for osteoarthritis

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

UC Davis docs find a way to create "movies" of wrist in motion using magnetic resonance imaging scans

Personalized asthma strategies needed to tackle comorbidities

Personalized asthma strategies needed to tackle comorbidities

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

FIDELITY project compares surgical treatment of degenerative meniscal tears to placebo surgery

Surgeons at French hospital perform first Navio UKR procedures

Surgeons at French hospital perform first Navio UKR procedures

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

Nuvo Research, NovaMedica enter into agreement to market Pennsaid products in Russia

Osteoarthritis patients can carry out progressive exercise to maintain bone health

Osteoarthritis patients can carry out progressive exercise to maintain bone health

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

Exercise in middle age protects against sarcopenia and maintains muscle strength, physical performance

UCLA stem cell researchers track early development of human articular cartilage

UCLA stem cell researchers track early development of human articular cartilage

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Eli Lilly reports edivoxetine Phase III program did not meet primary endpoint for major depressive disorder

Eli Lilly reports edivoxetine Phase III program did not meet primary endpoint for major depressive disorder

Ergoresearch first quarter fiscal 2014 revenues increase 95%

Ergoresearch first quarter fiscal 2014 revenues increase 95%

KKR to acquire minority stake in Gland Pharma for about $200 million

KKR to acquire minority stake in Gland Pharma for about $200 million

Inhibition of complement system plays major role in xenograft rejection

Inhibition of complement system plays major role in xenograft rejection

Chronic diseases account for increasing proportion of GPs' workload

Chronic diseases account for increasing proportion of GPs' workload

Radiofrequency neurotomy may be successful alternative treatment for knee osteoarthritis

Radiofrequency neurotomy may be successful alternative treatment for knee osteoarthritis

Scientists to develop on-demand drug-delivery system for pain management in osteoarthritis patients

Scientists to develop on-demand drug-delivery system for pain management in osteoarthritis patients

Web-based, at-home interventions help mothers address behaviors to protect against childhood obesity

Web-based, at-home interventions help mothers address behaviors to protect against childhood obesity

Cellular Biomedicine Group gets approval to conduct ReJoin Phase IIb trial for Knee Osteoarthritis

Cellular Biomedicine Group gets approval to conduct ReJoin Phase IIb trial for Knee Osteoarthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.